跳至主要内容
临床试验/NCT00477724
NCT00477724Unknown不适用

Incidence of Latent Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension After Endarterectomy and Influence of Exercise and Respiratory Therapy

Heidelberg University2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2007年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
35
试验地点
2
主要终点
Change in 6-Minute walking test

研究概览

简要总结

Severe CTEPH leads to an impaired physical capacity and a restricted quality of life and poor prognosis.

Pulmonary endarterectomy represents the best choice as therapy, when the thrombi are located in the central pulmonary vessels and therefore can be operated. By this operation the pulmonary artery pressure can be normalised and the patients' survival improved. Up to now, after successful endarterectomy patients only receive anticoagulation.

Despite operation many patients remain symptomatic and are restricted in their physical capacity. Therefore a hypothesis of this project is that most of the patients, even after successful operation, show peripheral vascular remodelling with a ventilation-perfusion mismatch and elevated pulmonary pressure during exercise.

In this study we aim to analyse how many patients with CTEPH after endarterectomy show elevated pulmonary artery pressures at rest or during exercise and are limited in their physical capacity, hemodynamics, oxygen uptake and quality of life and need further therapy.

Another aim is to examine whether exercise and respiratory therapy may improve the patients postoperatively.

Therefore 30 patients with CTEPH > six months after endarterectomy, with ongoing restricted exercise capacity shall be included. After baseline examination in the University hospital Heidelberg the patients receive exercise and respiratory therapy for three weeks. The patients will receive further examinations at the end of rehabilitation after 3 weeks and after 15 weeks. All examinations include medical history, family history, physical examination, ECG and echocardiography at rest and during exercise, cardiopulmonary exercise testing, assessment of the respiratory muscle strength, the SF-36 questionnaire for quality of life, laboratory testing and MRI.

Rehabilitation will be conducted in the clinic for rehabilitation Koenigstuhl, Heidelberg. Participants will be randomised into two groups, a control group receiving a conventional therapy for three weeks, in which physical exertion is to be avoided and a training group with additional exercise and respiratory therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A Screening
  • Informed consent
  • Men and women 18 - 75 years
  • Patients ≥ 6 months after endarterectomy because of chronic thromboembolic pulmonary hypertension (CTEPH)
  • B Training
  • See A + all patients who showed a restricted physical capacity in the screening:
  • Latent pulmonary hypertension
  • Restricted physical capacity

排除标准

  • Pregnancy or lactation
  • Change in medication during the last 2 months
  • Patients with signs of right heart decompensation
  • Disease which affects the gait
  • Unclear diagnosis
  • Acute illness, infection, fever
  • Severe lung diseases with FEV1 <50% and TLC< 70% of reference

结局指标

主要结局

Change in 6-Minute walking test

时间窗: after 3 and 15 weeks compared to baseline

Change in quality of life

时间窗: baseline and 15 weeks

次要结局

  • change of NTproBNP(baseline, 3 and 15 weeks)
  • noninvasive hemodynamic parameters(baseline, 3 and 15 weeks)
  • physical capacity in the ergometer test(baseline, 3 and 15 weeks)
  • change of lung function during 6-minute walking test(baseline, 3 and 15 weeks)
  • change of systolic pulmonary arterial pressure at rest and during exercise(baseline, 3 and 15 weeks)
  • change of WHO functional class(baseline, 3 and 15 weeks)
  • change of perfusion parameters (MRI)(baseline, 3 and 15 weeks)
  • change of respiratory muscle function(baseline and 15 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. med. Ekkehard Gruenig

Prof. Dr. med. Ekkehard Grünig

Heidelberg University

研究点 (2)

Loading locations...

相似试验